James Shin
Stock Analyst at Deutsche Bank
(1.56)
# 2,354
Out of 4,424 analysts
10
Total ratings
75%
Success rate
7.67%
Average return
Main Sectors:
Top Industries:
10 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly | Initiates: Hold | $535 | $771.55 | -30.66% | 1 | Nov 9, 2023 | |
| GILD Gilead Sciences | Initiates: Hold | $75 | $64.58 | +16.14% | 1 | Nov 9, 2023 | |
| BMY Bristol-Myers Squibb Company | Initiates: Hold | $55 | $44.74 | +22.93% | 1 | Nov 9, 2023 | |
| ABBV AbbVie | Initiates: Hold | $150 | $160.40 | -6.48% | 1 | Nov 9, 2023 | |
| REGN Regeneron Pharmaceuticals | Initiates: Hold | $800 | $968.00 | -17.36% | 1 | Nov 9, 2023 | |
| MRK Merck & Co. | Initiates: Buy | $115 | $130.23 | -11.69% | 1 | Nov 9, 2023 | |
| AMGN Amgen | Initiates: Hold | $240 | $312.86 | -23.29% | 1 | Nov 9, 2023 | |
| AUTL Autolus Therapeutics | Initiates: Buy | $10 | $4.17 | +139.81% | 1 | Nov 9, 2023 | |
| STRO Sutro Biopharma | Initiates: Buy | $12 | $4.35 | +175.86% | 1 | Nov 9, 2023 | |
| AFMD Affimed | Maintains: Overweight | $80 → $70 | $5.24 | +1,237.15% | 1 | Dec 12, 2022 |
Eli Lilly
Nov 9, 2023
Initiates: Hold
Price Target: $535
Current: $771.55
Upside: -30.66%
Gilead Sciences
Nov 9, 2023
Initiates: Hold
Price Target: $75
Current: $64.58
Upside: +16.14%
Bristol-Myers Squibb Company
Nov 9, 2023
Initiates: Hold
Price Target: $55
Current: $44.74
Upside: +22.93%
AbbVie
Nov 9, 2023
Initiates: Hold
Price Target: $150
Current: $160.40
Upside: -6.48%
Regeneron Pharmaceuticals
Nov 9, 2023
Initiates: Hold
Price Target: $800
Current: $968.00
Upside: -17.36%
Merck & Co.
Nov 9, 2023
Initiates: Buy
Price Target: $115
Current: $130.23
Upside: -11.69%
Amgen
Nov 9, 2023
Initiates: Hold
Price Target: $240
Current: $312.86
Upside: -23.29%
Autolus Therapeutics
Nov 9, 2023
Initiates: Buy
Price Target: $10
Current: $4.17
Upside: +139.81%
Sutro Biopharma
Nov 9, 2023
Initiates: Buy
Price Target: $12
Current: $4.35
Upside: +175.86%
Affimed
Dec 12, 2022
Maintains: Overweight
Price Target: $80 → $70
Current: $5.24
Upside: +1,237.15%